IRIS UniCatt

Racioppi, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.210
NA - Nord America 7.806
AS - Asia 5.053
SA - Sud America 920
Continente sconosciuto - Info sul continente non disponibili 241
AF - Africa 167
OC - Oceania 22
AN - Antartide 1
Totale 34.420
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.956
US - Stati Uniti d'America 7.539
SG - Singapore 2.259
DE - Germania 1.897
CN - Cina 1.153
SE - Svezia 906
NL - Olanda 873
FR - Francia 732
BR - Brasile 724
UA - Ucraina 486
VN - Vietnam 430
GB - Regno Unito 354
IN - India 294
IE - Irlanda 218
CA - Canada 150
ID - Indonesia 146
PL - Polonia 141
JP - Giappone 138
BD - Bangladesh 130
FI - Finlandia 130
RU - Federazione Russa 124
HK - Hong Kong 112
CH - Svizzera 90
TR - Turchia 70
AR - Argentina 69
ES - Italia 65
MX - Messico 58
BE - Belgio 52
IQ - Iraq 47
ZA - Sudafrica 41
CO - Colombia 31
KR - Corea 31
PK - Pakistan 30
EC - Ecuador 28
AT - Austria 25
CI - Costa d'Avorio 25
MA - Marocco 25
AL - Albania 22
RO - Romania 22
VE - Venezuela 22
AE - Emirati Arabi Uniti 19
AZ - Azerbaigian 18
IR - Iran 18
CL - Cile 17
PH - Filippine 17
SA - Arabia Saudita 17
EG - Egitto 15
AU - Australia 14
CR - Costa Rica 13
GR - Grecia 13
IL - Israele 13
LT - Lituania 13
MY - Malesia 13
NP - Nepal 13
TN - Tunisia 13
JO - Giordania 12
NG - Nigeria 12
UZ - Uzbekistan 12
PE - Perù 10
TT - Trinidad e Tobago 10
CZ - Repubblica Ceca 9
HU - Ungheria 9
TH - Thailandia 9
PT - Portogallo 8
TW - Taiwan 8
DZ - Algeria 7
LK - Sri Lanka 7
BO - Bolivia 6
EU - Europa 6
HN - Honduras 6
KE - Kenya 6
KG - Kirghizistan 6
NZ - Nuova Zelanda 6
OM - Oman 6
PA - Panama 6
RS - Serbia 6
SN - Senegal 6
UY - Uruguay 6
BG - Bulgaria 5
BY - Bielorussia 5
HR - Croazia 5
IS - Islanda 5
LV - Lettonia 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
SM - San Marino 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BB - Barbados 4
DK - Danimarca 4
ET - Etiopia 4
JM - Giamaica 4
KW - Kuwait 4
LB - Libano 4
NI - Nicaragua 4
SI - Slovenia 4
CV - Capo Verde 3
LU - Lussemburgo 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BZ - Belize 2
Totale 34.138
Salva come PNG Salva come JPEG
Città #
Milan 1.332
Singapore 1.219
Rome 1.202
Chandler 988
Ashburn 874
San Jose 725
Naples 415
Jacksonville 266
Florence 256
Los Angeles 245
Turin 242
Beijing 233
Dublin 208
San Mateo 205
Bologna 189
New York 181
Ann Arbor 169
Palermo 164
Bari 159
Ho Chi Minh City 147
Nanjing 147
Wilmington 143
Jakarta 134
Lauterbourg 134
Catania 126
Genoa 118
Hanoi 107
Verona 106
Munich 103
Hong Kong 99
Frankfurt am Main 96
Hefei 96
The Dalles 91
Dearborn 90
São Paulo 87
Bremen 85
Nürnberg 85
Boston 83
Kraków 82
Tokyo 82
Woodbridge 76
Nanchang 75
Dallas 72
Lawrence 71
Brescia 69
Moscow 69
Santa Clara 68
Houston 65
Marseille 63
Redwood City 63
Padova 58
Buffalo 56
Cagliari 53
Parma 50
Seattle 49
Venice 49
Chicago 48
Taranto 47
Pescara 45
Hyderabad 43
Reggio Emilia 43
Perugia 42
Bergamo 41
Lancaster 41
Ottawa 40
Atlanta 39
Princeton 39
Brussels 38
Messina 38
Mountain View 36
Salerno 36
Toronto 36
Cattolica 34
Orem 33
Stockholm 33
Fairfield 32
Livorno 32
London 32
Paris 32
Helsinki 31
Amsterdam 29
Lucca 29
Montreal 29
Redmond 29
Tianjin 29
Kadoma 28
Falls Church 27
Modena 27
Phoenix 27
Trieste 27
Kent 26
Kunming 26
Monza 26
Rimini 26
Abidjan 25
Boardman 25
Johannesburg 25
Seoul 25
Augusta 24
Novara 24
Totale 13.963
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 12.280
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.246
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 1.004
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 620
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 437
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 361
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 329
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 329
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 321
Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis 277
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 255
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 242
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position 234
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 218
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 212
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 204
The occult urothelial cancer 201
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 194
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 192
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 191
Haemodynamic changes detected during open prostatectomy and transurethral resection for benign prostatic hyperplasia 187
Male infertility: non-surgical therapy 184
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 182
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 178
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 176
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 176
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 175
Size of Bladder Cancers: Correlation among Different Types of Measurement 173
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 173
[Overactive bladder syndrome: the social and economic perspective] 172
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 172
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 172
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 172
Hot topics in urological health economics. A mini review 171
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 170
Imaging in prostate cancer diagnosis: present role and future perspectives 169
Therapeutic strategies in penile cancer: state of the art 169
Bladder and prostate metastasis from small cell lung cancer: a rare entity 169
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes 168
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 166
Antibiotic prophylaxis in urology 165
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 164
Acid-base and electrolyte balance in urinary intestinal orthotopic reservoir: ileocecal neobladder compared with ileal neobladder 162
The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome 161
Advanced bladder cancer: New agents and new approaches. A review 160
Imaging of renal cell carcinoma: state of the art and recent advances 158
Imaging in prostate cancer staging: present role e future perspectives 157
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 157
NBI: results review 156
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 156
Long-term behaviour of secretory immunity in ileocecal and ileal orthotopic neobladders. 154
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 154
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 154
Bradeion (SEPT4) as a Urinary Marker of Transitional Cell Bladder Cancer: A Real-Time Polymerase Chain Reaction Study of Gene Expression 154
[Innovative treatments of non muscle invasive bladder cancer] 153
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 150
Advanced bladder cancer: New agents and new approaches. A review 149
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 146
Imaging in prostate cancer staging: present role and future perspectives 146
Circumcision: history, religion and law 145
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 145
Simultaneous surgical management of renal cancer with atrial thrombotic extension and severe chronic coronary artery disease: a case report 143
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 143
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 142
Is extracorporeal shock wave lithotripsy in pediatrics a safe procedure? 140
Postoperative nomogram for invasive bladder cancer: Does it really work? A multicenter cohort study 140
Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study 140
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 140
Improved non-invasive diagnosis of bladder cancer with an electronic nose: A large pilot study 139
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 136
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 136
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 136
Vitamin B12 and folic acid plasma levels after ileocecal and ileal neobladder reconstruction 134
The occult urothelial cancer 134
Imaging of renal cell carcinoma: state of the art and recent advances 133
Mitomycin C: new strategies to improve efficacy of a well-known therapy 133
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 132
Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit 132
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study. 132
Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study 130
Therapy for non-muscle invasive bladder cancer: HP-NAP 130
Second-line intravesical therapy. What is the present role of device-assisted therapy? 129
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 126
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 125
Intensive intravesical mitomycin C therapy in non-muscle-invasive bladder cancer: a dose intensity approach. 123
[Doping and urologic tumors] 123
Imaging in prostate cancer diagnosis: present role and future perspectives 122
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 119
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients 118
Predictive Factors for Major Complications and Urological Cancer Diagnosis in Older Adults (≥80 Years) Admitted to the Emergency Department for Hematuria 115
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer? 115
Sports and Genitourinary Traumas 115
Quality of life following urinary diversion: Orthotopic ileal neobladder versus ileal conduit. A multicentre study among long-term, female bladder cancer survivors 115
Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process 113
Classification and management of sexual dysfunctions in multiple sclerosis patients: A review of current literature 112
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy 112
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer 112
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 110
Imaging of renal cell carcinoma: state of the art and recent advances. 108
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation 108
Totale 31.012
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.809
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.163 0 0 45 104 110 77 56 174 94 81 189 233
2022/20234.082 416 397 268 493 215 396 196 338 441 213 400 309
2023/20245.933 330 583 373 514 407 456 453 575 426 565 559 692
2024/20258.328 580 690 746 629 798 608 619 647 946 653 797 615
2025/20268.366 1.204 375 513 801 1.286 511 1.446 482 559 557 369 263
2026/2027983 411 498 74 0 0 0 0 0 0 0 0 0
Totale 34.420